Literature DB >> 7793882

Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity.

Y Cohen1, C Perronne, T Lazard, C Truffot-Pernot, J Grosset, J L Vilde, J J Pocidalo.   

Abstract

Several murine models have been used to evaluate the activities of antimicrobial agents against Mycobacterium avium infection. The main model used is the beige mouse model, but beige mice are expensive and not easily available. Thus, we developed a model of infection in wild C57BL/6 mice. The drugs that exhibited some activity in a previous model of early infection were evaluated in a new model of established infection. Sparfloxacin (50 mg/kg of body weight), ethambutol (50 mg/kg), minocycline (25 mg/kg), and the inhibitor of the cortisol receptors RU-40555 (100 mg/kg) were compared with clarithromycin (50 mg/kg). Treatments were started 5 weeks after the inoculation and were continued for 21 days. Sparfloxacin and RU-40555, which exhibited a moderate activity in the model of early infection, were not effective in this model of established infection. Clarithromycin and combinations with clarithromycin kept their activities against M. avium infection, both in the spleen and in lungs. The present model of established infection of normal C57BL/6 mice is more relevant than the model of early infection for a stringent evaluation of drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793882      PMCID: PMC162614          DOI: 10.1128/AAC.39.3.735

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex.

Authors:  M A Bertram; C B Inderlied; S Yadegar; P Kolanoski; J K Yamada; L S Young
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

2.  Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections.

Authors:  P R Gangadharam; V K Perumal; B T Jairam; P N Rao; A K Nguyen; D C Farhi; M D Iseman
Journal:  Am Rev Respir Dis       Date:  1987-08

3.  Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice.

Authors:  S K Furney; A D Roberts; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

Authors:  T Lazard; C Perronne; Y Cohen; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages.

Authors:  Y Cohen; C Perronne; C Truffot-Pernot; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

6.  Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.

Authors:  T Lazard; C Perronne; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

7.  Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.

Authors:  C Perronne; A Gikas; C Truffot-Pernot; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results.

Authors:  P R Gangadharam; C K Edwards; P S Murthy; P F Pratt
Journal:  Am Rev Respir Dis       Date:  1983-05

9.  Mycobacterium avium-complex infections in normal and immunodeficient mice.

Authors:  F M Collins; R W Stokes
Journal:  Tubercle       Date:  1987-06

10.  Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.

Authors:  C Truffot-Pernot; B Ji; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more
  2 in total

1.  Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.

Authors:  M Brun-Pascaud; P Rajagopalan-Levasseur; F Chau; G Bertrand; L Garry; F Derouin; P M Girard
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice.

Authors:  L Struillou; Y Cohen; N Lounis; G Bertrand; J Grosset; J L Vildé; J J Pocidalo; C Perronne
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.